decisionhealth Newsletters, Coder Pink Sheets - 2003 Issue 7 (July)
ABN for OPT
Subscribe or sign in to view the full article.
Article Overview
This article discusses how an ophthalmology practice should handle Medicare coverage, patient notification, and documentation when photodynamic therapy is considered for age-related macular degeneration. It also summarizes related billing considerations for the procedure, the associated drug, and common diagnostic imaging used in evaluating and following choroidal neovascularization. The piece is aimed at coders, billers, and ophthalmology staff who need a general understanding of the surrounding coverage and claim-reporting issues.
Why This Topic Matters
Coverage policy, patient liability notices, and documentation requirements can affect whether claims are paid and whether the patient is informed before treatment. The article also highlights that related procedure and drug reporting changed over time, making correct code selection important for ophthalmology billing workflows.
What You Will Learn
- How Medicare coverage considerations affect photodynamic therapy in ophthalmology
- Why patient notification and advance beneficiary notice handling are relevant to treatment planning
- Which general billing areas are involved for the procedure, infusion, and drug supply
- What documentation and diagnostic imaging are discussed in relation to choroidal neovascularization
- Why carrier-specific medical necessity guidance may affect claim support
Who Should Read This
- Medical coders
- Medical billers
- Ophthalmology practice staff
- Retina specialists
- Compliance staff
Codes Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com